<?xml version="1.0" encoding="UTF-8"?>
<p id="p0060">Many recent emerging infectious diseases, including Ebola, HIV/AIDS, and Zika, have had neuropsychiatric sequelae. Although no virus-mediated neuropsychiatric syndromes have yet been described from COVID-19, the absence of such syndromes has not been confirmed. Furthermore, there is evidence that the SARS-Cov-2 virus may target the CNS [
 <xref rid="bb0080" ref-type="bibr">16</xref>]. Identifying and understanding neuropsychiatric manifestations of novel pathogens is an important role for consulting psychiatrists, many of whom may recognize subtle symptoms or patterns overlooked by non-psychiatric clinicians. To that end, operationalized ways of collecting data on consultations provided to patients with emerging infections should be created and shared across institutions for rapid pattern identification and data consolidation.
</p>
